Wed, 17th Apr 2019 18:11
LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.
Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a further 4,000 at GBP0.81 on Tuesday, for a total of GBP40,730.
Karis now holds an interest in 86,667 shares, which represents 0.001% of Shield Therapeutics' entire issued share capital.
Shares in Shield Therapeutics closed down 1.3% Wednesday at 77.50p each.
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
(Alliance News) - Stock prices in London closed lower on Wednesday, as investors anxiously look ahead to this evening's Federal Open Market Committee ...
(Alliance News) - Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was overshadowed by a mis...
Shield Therapeutics PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag as chief financ...
Shield Thera (STX)